187 related articles for article (PubMed ID: 1070555)
1. Evaluation and selection of activated carbon for hemoperfusion.
Walker JM; Denti E; Van Wagenen R; Andrade JD
Kidney Int Suppl; 1976 Dec; (7):S320-7. PubMed ID: 1070555
[No Abstract] [Full Text] [Related]
2. Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure.
Chang TM
Kidney Int Suppl; 1976 Dec; (7):S305-11. PubMed ID: 1070552
[No Abstract] [Full Text] [Related]
3. The rationale for fixed-bed charcoal in hemoperfusion.
Hill JB; Palaia FL; McAdams JL; Palmer PJ; Skinner JT; Maret SM
Kidney Int Suppl; 1976 Dec; (7):S328-32. PubMed ID: 1070556
[No Abstract] [Full Text] [Related]
4. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure.
Chang TM
Kidney Int Suppl; 1975 Feb; (3):387-92. PubMed ID: 1099317
[No Abstract] [Full Text] [Related]
5. [Treatment of comatose patients by extracorporeal hemoperfusion with activated charcoal].
Lie TS; Kim WI; Rommelsheim K; Holst A
MMW Munch Med Wochenschr; 1976 Jul; 118(29-30):945-8. PubMed ID: 820984
[TBL] [Abstract][Full Text] [Related]
6. Short-term evaluation of charcoal hemoperfusion combined with dialysis in uremic patients.
Winchester JF; Apiliga MT; Kennedy AC
Kidney Int Suppl; 1976 Dec; (7):S315-9. PubMed ID: 1070554
[No Abstract] [Full Text] [Related]
7. Fixed-bed charcoal hemoperfusion for the treatment of drug overdose.
Barbour BH; LaSette AM; Koffler A
Kidney Int Suppl; 1976 Dec; (7):S333-7. PubMed ID: 1070557
[No Abstract] [Full Text] [Related]
8. Improved hemoperfusion systems for renal-hepatic support.
Nosé Y; Malchesky PS; Castino F; Koshino I; Scheucher K; Nokoff R
Kidney Int Suppl; 1976 Dec; (7):S244-7. PubMed ID: 1070539
[No Abstract] [Full Text] [Related]
9. Sorbent augmented dialysis: minor addition or major advance in therapy?
Winchester JF; Ronco C; Brady JA; Golds E; Clemmer J; Cowgill LD; Muller TE; Levin NW
Blood Purif; 2001; 19(2):255-9. PubMed ID: 11150820
[No Abstract] [Full Text] [Related]
10. [Adsorbents in extrarenal purification of the body].
Gorbovitskiĭ EB; Levitskiĭ ER
Vestn Akad Med Nauk SSSR; 1978; (1):79-87. PubMed ID: 343427
[No Abstract] [Full Text] [Related]
11. Sorbent membrane dialysis in uremia.
Randerson DH; Gurland HJ; Schmidt B; Farrell PC; Hone PW; Stokoe C; Zuber A; Blogg A; Fateh-Moghadam A; Marschner I; Köpcke W
Contrib Nephrol; 1982; 29():53-64. PubMed ID: 7075216
[TBL] [Abstract][Full Text] [Related]
12. Adsorbents in hemoperfusion.
Denti E; Luboz MP; Tessore VA; Castino F; Gaglia PF
Kidney Int Suppl; 1975 Feb; (3):401-5. PubMed ID: 1057716
[No Abstract] [Full Text] [Related]
13. Expectations for sorbents in uremia.
Merrill JP
Kidney Int Suppl; 1976 Dec; (7):S351-2. PubMed ID: 1070562
[No Abstract] [Full Text] [Related]
14. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
Chang TM
Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
[TBL] [Abstract][Full Text] [Related]
15. Use of combined hemodialysis/hemoperfusion in chronic uremia.
Stefoni S; Feliciangeli G; Colì L; Prandini R; Bonomini V
Contrib Nephrol; 1982; 29():123-32. PubMed ID: 6804167
[TBL] [Abstract][Full Text] [Related]
16. Present and future uses of hemoperfusion with sorbents.
Winchester JF; Gelfand MC; Knepshield JH; Schreiner GE
Artif Organs; 1978 Nov; 2(4):353-8. PubMed ID: 743004
[No Abstract] [Full Text] [Related]
17. Hemoperfusion: state of the art and future requirements.
Sideman S; Chang TM
Artif Organs; 1980 Feb; 4(1):70-5. PubMed ID: 7369897
[No Abstract] [Full Text] [Related]
18. [Results of more than 6 months of hemodialytic treatment with a new type of adsorbent membrane].
Giorcelli G; Linari F; Marangella F; Bajardi P; Vacha G; Zaffino MC
Minerva Nefrol; 1979; 26(2):189-90. PubMed ID: 471348
[No Abstract] [Full Text] [Related]
19. Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane-coated activated charcoal.
Chang TM; Gonda A; Dirks JH; Malave N
Trans Am Soc Artif Intern Organs; 1971; 17():246-52. PubMed ID: 5158100
[No Abstract] [Full Text] [Related]
20. Gastrointestinal clearance of drugs with activated charcoal.
Levy G
N Engl J Med; 1982 Sep; 307(11):676-8. PubMed ID: 7110218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
